1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

"Prescription Pharmaceutical Market Sales Overview" Published

New Pharmaceuticals market report from Datamonitor: "Prescription Pharmaceutical Market Sales Overview - Analysis of prescription pharmaceutical sales across 12 major markets"

 
PRLog - Mar. 16, 2011 - Prescription pharmaceutical sales in the world's major markets (US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Russia, China and India) totaled $555bn in 2009, having grown by 6.3% during 2008-09, and at a compound annual growth rate (CAGR) of 5.6% between 2005 and 2009.
Features and benefits

* Analyzes the size and growth (in terms of volume and value) of the 12 major prescription pharmaceutical markets
* Examines the prescription pharmaceutical sales growth trends across the various different therapy areas
* Assesses the leading prescription pharmaceutical brands across the each of the 12 major pharma markets
* Profiles the leading multinational and domestic pharma companies operating in each of the 12 major pharma markets.

Highlights

The US prescription pharmaceutical market generated half (50.3%) of the sales of the 12 markets analyzed, with $279bn in 2009, with sales having grown by 5.0% (CAGR, 2005-09) and 5.5% (2008-09). However, future sales growth will be shaped by three key events: the US economic downturn, healthcare reform and the patent cliff.The five major European markets (UK, Germany, France, Italy and Spain) generated sales of $143bn in 2009. However, ongoing austerity measures targeted at reducing healthcare expenditure, through driving up generic penetration as well as price cuts (on branded and generic drugs) will dampen growth going forward.Growth in the emerging markets is driven by their rapidly growing economies and populations; expansion of healthcare systems and health insurance policies, increasing access to drugs; and the emergence of middle classes with disposable incomes, who are more likely to spend money on branded generics and branded pharmaceuticals.
Your key questions answered

* Evaluate the evolving prescription pharmaceutical landscape and how this is set to impact Pharma out to 2015
* Quantify the size and growth of the 12 major pharmaceutical markets, analyzing key therapy areas, brands and companies
* Assess drivers and resistors of the prescription pharmaceutical market


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/109706_prescription_pharmaceut...


Partial Table of Contents:

Executive Summary
Introduction
Strategic scoping and focus
12 Major markets - Key Findings
Pharmaceutical market size
Leading therapy areas
Leading prescription pharmaceutical brands
Leading pharmaceutical companies
Related reports
4. 12 MAJOR MARKETS - PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS
12 Major markets - Key Findings
Pharmaceutical market size
Leading therapy areas
Leading prescription pharmaceutical brands
Leading pharmaceutical companies
12 Major markets - Pharmaceutical market size
The US pharmaceutical market while the largest will decline through 2015
Cost-containment policies throughout Europe translate in modest growth
Brand loyal Japan aims to boost its generics industry
Australia's small pharmaceutical market is also undertaking cost-cutting measures
The emerging markets showed the fastest growth rates
Global forecast sales for the top 50 pharma companies
12 Major markets - Leading therapy areas
The CNS and cardiovascular markets will experience sales declines out to 2015 due to increasing generic competition
Metabolic, oncology and oncology markets driven by biologic sales growth
Chinese medicines are the fastest growing drug group
12 Major markets - Leading pharmaceutical brands
Lipitor is to experience a dramatic loss in sales due to its looming patent expiry
Plavix is the industry-leading antithrombotic and is supported by a wealth of post-launch data
Nexium growth is attributed to its gold standard status and extensive patient switching, but sales are forecast to decline
12 Major markets - Leading pharmaceutical companies
Pfizer
Merck & Co.
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi-Aventis
Roche
Johnson & Johnson
Eli Lilly
Takeda
3. US - PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS
US - Key findings
Pharmaceutical market size
Leading therapy areas
Leading prescription pharmaceutical brands
Leading pharmaceutical companies
US - Pharmaceutical market size
US - Leading therapy areas
Metabolic drugs exhibited the strongest sales growth during 2005-09
Central nervous system drugs hold the largest value share of the US market
Cardiovascular drugs saw declining sales
Leading therapy areas out to 2015 (for the top 50 pharma companies)
US - Leading pharmaceutical brands
Lipitor has suffered sales erosion die to availability of other generic statins
Nexium growth is attributed to its gold standard status and extensive patient switching, but sales are forecast to decline
Plavix is the industry-leading antithrombotic and is supported by a wealth of post-launch data
US - Leading pharmaceutical companies
The top 10 pharmaceutical companies in the US
Forecast sales for the top 10 pharmaceutical companies in 2015
The top 10 US-based pharmaceutical companies
Pfizer
Merck & Co.
Johnson & Johnson
4. JAPAN - PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS
Japan - Key findings
Pharmaceutical market size
Leading therapy areas
Leading prescription pharmaceutical brands
Leading pharmaceutical companies
Japan - Pharmaceutical market size
Japan - Leading therapy areas
Cardiovascular drugs hold the largest value share of the Japanese market

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1097...

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
Phone:1.800.844.8156
Zip:01267
Location:Massachusetts - United States
Industry:Medical, Research, Biotech
Tags:pharmaceutical, prescription, therapy, drug, generic, publications, exhibited, articles, pharma, lipitor
Shortcut:prlog.org/11376543
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share